Lexaria Bioscience agrees to sell non-pharmaceutic
Post# of 721
(Total Views: 241)
Posted On: 11/19/2020 7:49:08 PM
Lexaria Bioscience agrees to sell non-pharmaceutical THC related assets for 3.85 million
Proactive
32 000 prenumeranter
Lexaria Bioscience (CSE: LXX- OTC: LXRP) CEO Chris Bunka joined Steve Darling from Proactive with news the company has agreed to sell certain non-core, non-pharmaceutical THC-related business assets to Hill Street Beverage for 3.85 million Canadian.
https://youtu.be/mHthJx3ObGU
Bunka also told Proactive “Hill Street is acquiring royalty-free and perpetual global rights including relicensing rights of Lexaria's DehydraTECH technology” He also said Lexaria retains full ownership of its DehydraTECH technology.
Proactive
32 000 prenumeranter
Lexaria Bioscience (CSE: LXX- OTC: LXRP) CEO Chris Bunka joined Steve Darling from Proactive with news the company has agreed to sell certain non-core, non-pharmaceutical THC-related business assets to Hill Street Beverage for 3.85 million Canadian.
https://youtu.be/mHthJx3ObGU
Bunka also told Proactive “Hill Street is acquiring royalty-free and perpetual global rights including relicensing rights of Lexaria's DehydraTECH technology” He also said Lexaria retains full ownership of its DehydraTECH technology.
(1)
(0)Lexaria Bioscience Corp. (LXRPD) Stock Research Links
Robert
Scroll down for more posts ▼